Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II study of intravenous vonoprazan fumarate for bleeding peptic ulcer
CTR20250180Phase 2Completed
- Sponsor
- Shandong New Era Pharmaceutical
- Start
- Mar 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of vonoprazan in Peptic ulcer disease (PUD), upper gastrointestinal bleeding (UGIB), sponsored by Shandong New Era Pharmaceutical. Started Mar 2025; status: completed.
02
Drugs
vonoprazan
03
Conditions
Peptic ulcer disease (PUD)upper gastrointestinal bleeding (UGIB)
Beyond the preview
Go deeper on CTR20250180.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20250180.